Does anyone think it odd that the principal investigator in a clinical trial in patients with an infectious disease and with respiratory failure is Prof Tony Goldschlager, a NEUROSURGEON, a specialist in brain, spine and pituitary Surgery? Well that is a new one for me. Guess he is multi-tasking.
Ann: Ethics Approval to Treat COVID-19 Patients in Australia, page-263
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.41 |
Change
0.060(4.44%) |
Mkt cap ! $1.552B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $2.455M | 1.788M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 16990 | $1.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.42 | 39322 | 4 |
View Market Depth
| Last trade - 13.31pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |